Recursion Pharmaceuticals Files Underwriting Agreement for Share Sale
Recursion Pharmaceuticals agreed to issue and sell 61.54 million Class A shares via an underwriting agreement. This represents a new equity offering.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed